Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText.
Kick-your-searchterm to multiple Engines kick-your-query now !>
A dictionary by aggregated review articles of nephrology, medicine and the life sciences
Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

suck abstract from ncbi


10.1016/j.virol.2021.01.003

http://scihub22266oqcxt.onion/10.1016/j.virol.2021.01.003
suck pdf from google scholar
33714753!7849420!33714753
unlimited free pdf from europmc33714753    free
PDF from PMC    free
html from PMC    free

suck abstract from ncbi


Deprecated: Implicit conversion from float 229.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534

Deprecated: Implicit conversion from float 229.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
pmid33714753      Virology 2021 ; 558 (ä): 28-37
Nephropedia Template TP

gab.com Text

Twit Text FOAVip

Twit Text #

English Wikipedia


  • Development of a SARS-CoV-2 nucleocapsid specific monoclonal antibody #MMPMID33714753
  • Terry JS; Anderson LB; Scherman MS; McAlister CE; Perera R; Schountz T; Geiss BJ
  • Virology 2021[Jun]; 558 (ä): 28-37 PMID33714753show ga
  • To help fight COVID-19, new molecular tools specifically targeting critical components of the causative agent of COVID-19, SARS-Coronavirus-2 (SARS-CoV-2), are desperately needed. The SARS-CoV-2 nucleocapsid protein is critical for viral replication, integral to viral particle assembly, and a major diagnostic marker for infection and immune protection. Currently the limited available antibody reagents targeting the nucleocapsid protein are not specific to SARS-CoV-2 nucleocapsid protein, and sequences for these antibodies are not publicly available. In this work we developed and characterized a series of new mouse monoclonal antibodies against the SARS-CoV-2 nucleocapsid protein, with a specific clone, mBG86, targeting only SARS-CoV-2 nucleocapsid protein. The monoclonal antibodies were validated in ELISA, Western blot, and immunofluorescence analyses. The variable regions from six select clones were cloned and sequenced, and preliminary epitope mapping of the sequenced clones was performed. Overall, these new antibody reagents will be of significant value in the fight against COVID-19.
  • |*Antibodies, Monoclonal/immunology/isolation & purification[MESH]
  • |*Antibodies, Viral/immunology/isolation & purification[MESH]
  • |Animals[MESH]
  • |COVID-19/epidemiology/*immunology[MESH]
  • |Cloning, Molecular[MESH]
  • |Coronavirus Nucleocapsid Proteins/*immunology[MESH]
  • |Escherichia coli[MESH]
  • |Female[MESH]
  • |Humans[MESH]
  • |Mice[MESH]
  • |Mice, Inbred BALB C[MESH]
  • |Phosphoproteins/immunology[MESH]
  • |Recombinant Proteins/immunology[MESH]


  • DeepDyve
  • Pubget Overpricing
  • suck abstract from ncbi

    Linkout box